CLINICAL_TRIALS
withdrawal
· 2011-06-01
Clinical Trial Update: Zonisamide for Fibromyalgia & Migraine [Phase 4]
Summary
A Phase 4 clinical trial evaluating zonisamide for fibromyalgia and migraine has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Fibromyalgia, Migraine | Phase 4 | Status: WITHDRAWN